Cefquinome sulfate behavior after intramammary administration in healthy and infected cows

Journal of Dairy Science

Volumn 94, Issue 7, 2011, Pages 3455-3461

  Zonca, A ^a   Gallo, M ^a   Locatelli, C ^a   Carli, S ^a   Moroni, P ^a,b   Villa, R ^a   Cagnardi, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Cefquinome sulfate; Lactating intramammary treatment; Minimum inhibitory concentration

Indexed keywords

ANTIINFECTIVE AGENT; CEFQUINOME; CEPHALOSPORIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE MASTITIS; CATTLE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; FEMALE; ISOLATION AND PURIFICATION; LACTATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UDDER;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEPHALOSPORINS; DRUG ADMINISTRATION ROUTES; FEMALE; LACTATION; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANIMALIA; BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 79959357015     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2010-4109     Document Type: Article

References (27)

1. Barragry T.B. Bovine mastitis. Veterinary Drug Therapy 1994, Lea & Febiger, Philadelphia, PA, Pages 655-688.
2. Böttner A., Schmid P., Humke R. In vitro efficacy of Cefquinome (INN) and other anti-infective drugs against bovine bacterial isolates from Belgium, France, Germany, the Netherlands and the United Kingdom. Zentralbl. Veterinarmed. B 1995, 42:377-383.
3. Bradley A.J., Green M.J. Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations. J. Dairy Sci. 2009, 92:1941-1953.
4. Cagnardi P., Villa R., Gallo M., Locatelli C., Carli S., Moroni P., Zonca A. Cefoperazone sodium preparation behavior after intramammary administration in healthy and infected cows. J. Dairy Sci. 2010, 93:4105-4110.
5. Constable P.D., Morin D.E. Treatment of clinical mastitis using antimicrobial susceptibility profiles for treatment decisions. Vet. Clin. North Am. Food Anim. Pract. 2003, 19:139-155.
6. CVMP. 1995. Cefquinome. Summary Report. EMEA/MRL/005/95. European Agency for the Evaluation of Medicinal Products, London, UK.
7. CVMP. 2003. Cefquinome (Extension to Horses). Summary Report (3). EMEA/MRL/883/03-FINAL. European Agency for the Evaluation of Medicinal Products, London, UK.
8. Ehinger A.M., Schmidt H., Kietzmann M. Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder. Vet. J. 2006, 172:147-153.
9. FDA. 2008. CVM Updates, Cephalosporin Order of Prohibition Questions and Answers, July 16, 2008. US Food and Drug Administration, Washington, DC.
10. Gehring R., Smith G.W. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. J. Vet. Pharmacol. Ther. 2006, 29:237-241.
11. Gibaldi M., Perrier D. Noncompartmental analysis based on statistical moment Theory. Pharmacokinetics 1982, Marcel Dekker Inc., New York, NY, Pages 409-417.
12. Guerin-Faublée V., Carret G., Houffschmitt P. In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis. Vet. Rec. 2003, 152:466-471.
13. Holdaway R.J., Holmes C.W., Steffert I.J. A comparison of indirect methods for diagnosis of subclinical intramammary infection in lactating dairy cows. Aust. J. Dairy Technol. 1996, 51:64-78.
14. Limbert M., Isert D., Klesel N., Markus A., Seeger K., Seibert G., Schrinner E. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 1991, 35:14-19.
15. McKellar Q.A., Sanchez Bruni S.F., Jones D.G. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J. Vet. Pharmacol. Ther. 2004, 27:503-514.
16. National Committee for Clinical Laboratory Standards. 2002. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard. Document M31-A2. 2nd ed. NCCLS (now CLSI), Wayne, PA.
17. Laboratory Handbook on Bovine Mastitis 1999, National Mastitis Council, National Mastitis Council Inc., Madison, WI.
18. Nutrient Requirements of Dairy Cows 2001, National Research Council, National Academy Press, Washington, DC. 7th rev. ed.
19. Oshima M., Yoshida T. Quarter difference in milk hydrogen ion concentration is superior to milk pH for diagnosis of subclinical mastitis. Jpn. J. Zootech. Sci. 1988, 59:95-98.
20. Prescott J.F. Beta-lactam antibiotics: Cephalosporins. Antimicrobial Therapy in Veterinary Medicine 2006, 139-157. Blackwell Publishing, Ames, IA. 4th ed. S. Giguere, J.F. Prescott, J.D. Baggot, R.D. Walker, P.M. Dowling (Eds.).
21. Schmid P., Thomas V. Cefquinome-Eight years of antimicrobial susceptibility surveillance in cattle. Proc. XXII World Buiatrics Congress 2002, 456-764. 147.
22. Shpigel N.Y., Kass P.H., Saran A. A comparative randomized field trial on intramammary and intramuscular dry cow antibiotic treatment of subclinical Staphylococcus aureus mastitis in dairy cows. J. Vet. Med. A Physiol. Pathol. Clin. Med. 2006, 53:418-422.
23. Shpigel N.Y., Levin D., Winkler M., Saran A., Ziv G., Böttner A. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. J. Dairy Sci. 1997, 80:318-323.
24. Shpigel N.Y., Schmid P. Ein Beitrag zur Behandlung der akuten Mastitis des Rindes mit Cefquinom. Tierarztl. Prax. 1997, 25:200-206.
25. Stockler R.M., Morin D.E., Lantz R.K., Constable P.D. Effect of milking frequency and dosing interval on the pharmacokinetics of cephapirin after intramammary infusion in lactating dairy cows. J. Dairy Sci. 2009, 92:4262-4275.
26. Stockler R.M., Morin D.E., Lantz R.K., Hurley W.L., Constable P.D. Effect of milk fraction on concentrations of cephapirin and desacetylcephapirin in bovine milk after intramammary infusion of cephapirin sodium. J. Vet. Pharmacol. Ther. 2009, 32:345-352.
27. Wagner S., Erskine R. Antimicrobial drug use in bovine mastitis. Antimicrobial Therapy in Veterinary Medicine 2006, 507-517. Blackwell Publishing, Ames, IA. 4th ed. S. Giguere, J.F. Prescott, J.D. Baggot, R.D. Walker, P.M. Dowling (Eds.).